Lower riskDrug recall · FDA · Published October 5, 2021
Dr. Reddy's Omeprazole Capsules Recall: Staple Found in Bottles
Dr. Reddy's recalls 20 mg omeprazole capsules due to customer complaints about staples found inside bottles. Affected units contain a staple co-mingled with capsules.
“Dr. Reddy's Omeprazole Capsules Recall: Staple Found in Bottles.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35799-dr-reddy-s-omeprazole-capsules-recall-staple-found-in-bottles. Based on FDA recall #D-0026-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0026-2022%22&limit=1).
The FDA announced on 2021-10-05 that Dr. Reddy's Laboratories, Inc. voluntarily recalled Omeprazole Delayed-Release Capsules due to CGMP deviations involving a staple found in the product.
The recall was initiated following a customer complaint regarding the presence of a staple co-mingled with capsules within the bottle. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has had 85 other recalls on record since 2012-04-09. Recent brand-specific recalls include the 2025-11-11 Varenicline Tablets Recall for subpotent drug risk, the 2025-09-26 Succinylcholine Chloride Injection Recall for stability testing issues, and the 2025-06-30 Omeprazole Capsules Recall for foreign tablets found. Other recent recalls of similar products include Hikma Ramipril Capsules 10mg Recall (2026-08-24), Asclemed Duloxetine Capsules Recall (2026-05-14), and Zydus Clomipramine Capsules Recall (2025-10-22).
How to tell if you have this one
Check for the product name 'Omeprazole Delayed-Release Capsules, 20 mg', 24-hour, 14-count bottles with NDC 70000-0232-1. The product was distributed by Cardinal Health in the U.S.
Brand
Dr. Reddy's
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check for Staples
Inspect the bottle for any staples that may have been co-mingled with the capsules.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The recall is due to customer complaints about staples found inside bottles, not a safety issue with the product itself. Taking the capsules as directed should be safe.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0026-2022 (October 5, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0026-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.